Aurisco Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	449.21	354.79	289.42	210.96	168.71
Depreciation & Amortization	125.98	87.01	79.11	69.24	54.77
Other Amortization	2.33	3.2	2.54	1.55	-
Loss (Gain) From Sale of Assets	0.55	0.41	1.53	1.5	0.4
Asset Writedown & Restructuring Costs	8.44	0.17	-	-	-
Loss (Gain) From Sale of Investments	-6.56	-5.62	-31.72	1.19	-0.68
Provision & Write-off of Bad Debts	4.53	3.55	4.18	4.19	-0.09
Other Operating Activities	38.36	20.4	6	3.89	2.33
Change in Accounts Receivable	-125.57	-107.13	-98.18	-84.83	11.29
Change in Inventory	-121.19	-201.43	-72.52	-125.97	-89.01
Change in Accounts Payable	42.67	161.15	174.55	70.56	55.41
Change in Other Net Operating Assets	5.23	17.59	34.28	17.98	1
Operating Cash Flow	421.5	332.41	385.61	166.41	201.57
Operating Cash Flow Growth	26.80%	-13.80%	131.72%	-17.44%	-6.02%
Capital Expenditures	-350.07	-540.28	-305.48	-216.23	-250.61
Sale of Property, Plant & Equipment	1.04	1.28	0.52	0.63	0.6
Divestitures	-	-	61.09	-	-
Investment in Securities	100.29	-191.34	-121.44	-41.44	-15
Other Investing Activities	6.56	3.56	0.03	0.25	2.68
Investing Cash Flow	-242.19	-726.77	-365.27	-256.79	-262.34
Long-Term Debt Issued	66	986.04	135.79	37.12	-
Total Debt Issued	66	986.04	135.79	37.12	-
Long-Term Debt Repaid	-60	-153.64	-71.87	-5.94	-4.37
Total Debt Repaid	-60	-153.64	-71.87	-5.94	-4.37
Net Debt Issued (Repaid)	6	832.4	63.92	31.18	-4.37
Issuance of Common Stock	-	-	-	57.15	-
Common Dividends Paid	-124.12	-94.82	-67	-52.34	-48.12
Other Financing Activities	-63.3	-3.22	52.1	-50.9	-
Financing Cash Flow	-181.42	734.37	49.02	-14.91	-52.49
Foreign Exchange Rate Adjustments	-3.55	14.02	6.11	3.5	-3.82
Net Cash Flow	-5.66	354.02	75.47	-101.79	-117.08
Free Cash Flow	71.42	-207.87	80.13	-49.82	-49.04
Free Cash Flow Margin	4.21%	-14.09%	6.35%	-4.94%	-6.11%
Free Cash Flow Per Share	0.17	-0.52	0.20	-0.12	-0.12
Cash Income Tax Paid	-	-12.74	-18.15	-35.73	-27.6
Levered Free Cash Flow	-27.2	-303.79	36.02	-102.36	-116.14
Unlevered Free Cash Flow	-5.5	-293.93	37.73	-101.73	-115.74
Change in Working Capital	-201.33	-131.5	34.55	-126.11	-23.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.